Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

IRONWOOD PHARMACEUTICALS INC (IRWD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Silver Ronald (Principal Accounting Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 1,976 shares @ $10.04, valued at $19.8k
08/16/2023 4 John Minardo (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 7,045 shares @ $10.04, valued at $70.7k
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS U.S. Net Sales and Ironwood Revenue Guidance"
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/07/2023 SC 13D IRONWOOD PHARMACEUTICALS INC reports a 97.6% stake in VectivBio Holding AG
07/05/2023 SC 13G/A WESTFIELD CAPITAL MANAGEMENT CO LP reports a 0% stake in Ironwood Pharmaceuticals, Inc.
06/30/2023 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares BOSTON and BASEL, Switzerland – June 29, 2023 – Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, and VectivBio Holding AG , a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today announced the successful completion of the tender offer to purchase the outstanding ordinary shares of VectivBio for $17.00 per share in cash . The Depositary for the Tender Offer has advised Ironwood and VectivBio that at the end of the offering period, 59,287,753 Shares had been tendered and not withdrawn pursuant to the Tender Offer and it has received commitments to tender 2,007,310 additional Shares under the guaran..."
06/29/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/16/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 4 MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 26,632 shares @ $10.7, valued at $285k
05/31/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
05/30/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 4 Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 10,324 shares @ $10.12, valued at $104.5k
05/24/2023 4 Davis Andrew (SVP, Chief Business Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 6,305 shares @ $10.12, valued at $63.8k
05/24/2023 4 MCCOURT Thomas A (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 36,000 shares @ $10.12, valued at $364.3k
05/23/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 0% stake in Ironwood Pharamaceuticals, Inc.
05/08/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2023 4 Moukheibir Catherine (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 1,677 shares @ $0
03/17/2023 4 DENNER ALEXANDER J (10% Owner) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 1,438 shares @ $0
03/10/2023 4 Silver Ronald (Principal Accounting Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 35,620 shares @ $0
03/10/2023 4 Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 69,869 shares @ $0
Granted 34,935 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy